ORIGINAL RESEARCH article
Front. Pharmacol., 18 May 2022
Sec. Gastrointestinal and Hepatic Pharmacology
Volume 13 - 2022 | https://doi.org/10.3389/fphar.2022.874696
RETRACTED: Quercetin Inhibits Tumorigenesis of Colorectal Cancer Through Downregulation of hsa_circ_0006990
- BC
Bin Chen 1†
- LW
Linguangjin Wu 1†
- XT
Xiaoxia Tang 1†
- TW
Ting Wang 1
- SW
Shuyun Wang 1
- HY
Hongjie Yu 1
- GW
Guangsheng Wan 1
- MX
Manli Xie 1
- RZ
Ruijuan Zhang 2‡ *
- HX
Haijuan Xiao 3‡ *
- WD
Wanli Deng 1‡ *
1. Department of Oncology, Putuo Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai, China
2. Department of Traditional Chinese Medicine, Putuo People’s Hospital, Tongji University, Shanghai, China
3. Department of Oncology, Affiliated Hospital of Shaanxi University of Chinese Medicine, Xianyang, China
Summary
Citation
Chen B, Wu L, Tang X, Wang T, Wang S, Yu H, Wan G, Xie M, Zhang R, Xiao H and Deng W (2022) RETRACTED: Quercetin Inhibits Tumorigenesis of Colorectal Cancer Through Downregulation of hsa_circ_0006990. Front. Pharmacol. 13:874696. doi: 10.3389/fphar.2022.874696
Received
12 February 2022
Accepted
07 April 2022
Published
18 May 2022
Volume
13 - 2022
Edited by
Hailian Shi, Shanghai University of Traditional Chinese Medicine, China
Reviewed by
Liqun Jia, China-Japan Friendship Hospital, China
Li Feng, National Cancer Center of China, China
Updates
†These authors have contributed equally to this work and shared first authorship
‡These authors have contributed equally to this work and shared last authorship
This article was submitted to Gastrointestinal and Hepatic Pharmacology, a section of the journal Frontiers in Pharmacology
Disclaimer
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.